Therapeutic Goods Act 1989
Approval under section 42DF for use of a restricted representation by Medical Developments International Limited
I, Jane Cook, Head, Office of Product Review, Therapeutic Goods Administration and delegate of the Secretary to the Department of Health and Ageing, on receipt of an application from Medical Developments International Limited, have approved under section 42DF of the Therapeutic Goods Act 1989 (the Act) the restricted representations described in paragraph (a) below for use in advertisements directed to consumers, for the product identified in paragraph (b):
- "Asthma" and "Chronic Obstructive Pulmonary Disease (COPD)"
- Space Chamber Plus®, Compact Space Chamber Plus® and Space Chamber® - ARTG No. 142303
Dated this 10 day of September 2013
Jane Cook
Delegate of the Secretary to the Department of Health and Ageing; and
Head
Office of Product Review